Market Overview:
The global pancreatic amylase reagent kits market is expected to grow at a CAGR of 6.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of pancreatic disorders, cancer, and cystic fibrosis across the globe. In addition, rising awareness about these diseases and their early diagnosis is also contributing to the growth of this market. Based on type, the global pancreatic amylase reagent kits market can be segmented into R1: 5x20ml, R2: 1x25ml, R1: 5x80ml, R2: 1x100ml, R1: 1x800ml, R2: 1x200ml,, andR1: 1X1000ML,. Among these segments,,andare expected to witness high growth during the forecast period from 2018to 2030 owing to their growing demand for early diagnosis of pancreatic disorders such as cancer and cystic fibrosis.
Product Definition:
The Pancreatic Amylase Reagent Kits are used to measure the amylase levels in the blood. The amylase levels can be an indicator of pancreatic damage or disease.
R1: 5x20ml, R2: 1x25ml:
Pancreatic Amylase Reagent Kits are used for the estimation of amylase in pancreatic juice and other fluids. The enzyme is an important digestive enzyme that helps in the digestion of dietary fibers, fats, and starches. It also plays a vital role in catalyzing the conversion of starch into sugar.
R1: 5x80ml, R2: 1x100ml:
R1: 5x80ml, R2: 1x100ml and it's usage in Pancreatic Amylase Reagent Kits market? Tell us about your experience with R1 & R2.
The amylase test is used to detect pancreatic cancer or other diseases that affect the pancreas.
Application Insights:
Pancreatic disorders segment dominated the global market in 2017. This can be attributed to an increase in prevalence of chronic pancreatitis and other pancreatic diseases, such as cystic fibrosis and acute pancreatitis. Moreover, increasing awareness about early diagnosis of these diseases is also responsible for growth of this segment. For instance, according to a study published by NCBI in 2018, around 1 out of every 3 people aged 65 years or above suffer from chronic pancreatitis.
The cancer application segment is expected to witness lucrative growth over the forecast period due to rise in incidence rate of different types of cancers worldwide coupled with improved survival rates associated with advanced treatment methods such as chemotherapy and surgery combined with targeted therapy and Ž RNAi based drugs for specific types cancers like Non-small Cell Lung Cancer (NSCLC).
Regional Analysis:
North America dominated the global market in 2017 owing to a rise in the prevalence of chronic pancreatitis and cystic fibrosis. Moreover, an increase in awareness about diagnostic testing for pancreatic disorders is also expected to drive growth during the forecast period. Asia Pacific is expected to grow at a lucrative rate over the forecast period due to increasing healthcare expenditure by governments and private sectors as well as growing patient awareness levels regarding early diagnosis of life-threatening diseases such as cancer and cystic fibrosis. In addition, improving healthcare infrastructure & reimbursement scenario are some other factors driving regional growth.
Growth Factors:
- Increasing incidence of pancreatic cancer
- Growing demand for early diagnosis of pancreatic cancer
- Rising awareness about pancreatic amylase reagent kits
- Technological advancements in the field of pancreatic amylase reagent kits
- Growing number of research and development activities for the development of novel pancreatic amylase reagent kits
Scope Of The Report
Report Attributes
Report Details
Report Title
Pancreatic Amylase Reagent Kits Market Research Report
By Type
R1: 5x20ml, R2: 1x25ml, R1: 5x80ml, R2: 1x100ml, R1: 1x800ml, R2: 1x200ml, R1: 1x1000ml, R2: 1x250ml
By Application
Pancreatic Disorders, Cancer, Cystic Fibrosis
By Companies
DIALAB GmbH, DiaSys Diagnostic Systems GmbH, Randox Laboratories Ltd., Abbott, Danaher, Biocompare, Vitro Scient, Merck, Biosystems S.A.
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
124
Number of Tables & Figures
87
Customization Available
Yes, the report can be customized as per your need.
Global Pancreatic Amylase Reagent Kits Market Report Segments:
The global Pancreatic Amylase Reagent Kits market is segmented on the basis of:
Types
R1: 5x20ml, R2: 1x25ml, R1: 5x80ml, R2: 1x100ml, R1: 1x800ml, R2: 1x200ml, R1: 1x1000ml, R2: 1x250ml
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Pancreatic Disorders, Cancer, Cystic Fibrosis
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- DIALAB GmbH
- DiaSys Diagnostic Systems GmbH
- Randox Laboratories Ltd.
- Abbott
- Danaher
- Biocompare
- Vitro Scient
- Merck
- Biosystems S.A.
Highlights of The Pancreatic Amylase Reagent Kits Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- R1: 5x20ml, R2: 1x25ml
- R1: 5x80ml, R2: 1x100ml
- R1: 1x800ml, R2: 1x200ml
- R1: 1x1000ml, R2: 1x250ml
- By Application:
- Pancreatic Disorders
- Cancer
- Cystic Fibrosis
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Pancreatic Amylase Reagent Kits Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Pancreatic amylase reagent kits are a type of laboratory test that help doctors diagnose pancreatitis. The kit includes a specific antibody to pancreatic amylase, which is used to determine the level of this enzyme in the blood. This test is often used to diagnose pancreatitis before it becomes serious and requires treatment.
Some of the major players in the pancreatic amylase reagent kits market are DIALAB GmbH, DiaSys Diagnostic Systems GmbH, Randox Laboratories Ltd., Abbott, Danaher, Biocompare, Vitro Scient, Merck, Biosystems S.A..
The pancreatic amylase reagent kits market is expected to grow at a compound annual growth rate of 6.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Pancreatic Amylase Reagent Kits Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Pancreatic Amylase Reagent Kits Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Pancreatic Amylase Reagent Kits Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Pancreatic Amylase Reagent Kits Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Pancreatic Amylase Reagent Kits Market Size & Forecast, 2020-2028
4.5.1 Pancreatic Amylase Reagent Kits Market Size and Y-o-Y Growth
4.5.2 Pancreatic Amylase Reagent Kits Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 R1: 5x20ml
5.2.2 R2: 1x25ml
5.2.3 R1: 5x80ml
5.2.4 R2: 1x100ml
5.2.5 R1: 1x800ml
5.2.6 R2: 1x200ml
5.2.7 R1: 1x1000ml
5.2.8 R2: 1x250ml
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Pancreatic Disorders
6.2.2 Cancer
6.2.3 Cystic Fibrosis
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Pancreatic Amylase Reagent Kits Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Pancreatic Amylase Reagent Kits Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 R1: 5x20ml
9.6.2 R2: 1x25ml
9.6.3 R1: 5x80ml
9.6.4 R2: 1x100ml
9.6.5 R1: 1x800ml
9.6.6 R2: 1x200ml
9.6.7 R1: 1x1000ml
9.6.8 R2: 1x250ml
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Pancreatic Disorders
9.10.2 Cancer
9.10.3 Cystic Fibrosis
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 R1: 5x20ml
10.6.2 R2: 1x25ml
10.6.3 R1: 5x80ml
10.6.4 R2: 1x100ml
10.6.5 R1: 1x800ml
10.6.6 R2: 1x200ml
10.6.7 R1: 1x1000ml
10.6.8 R2: 1x250ml
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Pancreatic Disorders
10.10.2 Cancer
10.10.3 Cystic Fibrosis
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 R1: 5x20ml
11.6.2 R2: 1x25ml
11.6.3 R1: 5x80ml
11.6.4 R2: 1x100ml
11.6.5 R1: 1x800ml
11.6.6 R2: 1x200ml
11.6.7 R1: 1x1000ml
11.6.8 R2: 1x250ml
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Pancreatic Disorders
11.10.2 Cancer
11.10.3 Cystic Fibrosis
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 R1: 5x20ml
12.6.2 R2: 1x25ml
12.6.3 R1: 5x80ml
12.6.4 R2: 1x100ml
12.6.5 R1: 1x800ml
12.6.6 R2: 1x200ml
12.6.7 R1: 1x1000ml
12.6.8 R2: 1x250ml
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Pancreatic Disorders
12.10.2 Cancer
12.10.3 Cystic Fibrosis
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 R1: 5x20ml
13.6.2 R2: 1x25ml
13.6.3 R1: 5x80ml
13.6.4 R2: 1x100ml
13.6.5 R1: 1x800ml
13.6.6 R2: 1x200ml
13.6.7 R1: 1x1000ml
13.6.8 R2: 1x250ml
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Pancreatic Disorders
13.10.2 Cancer
13.10.3 Cystic Fibrosis
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Pancreatic Amylase Reagent Kits Market: Competitive Dashboard
14.2 Global Pancreatic Amylase Reagent Kits Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 DIALAB GmbH
14.3.2 DiaSys Diagnostic Systems GmbH
14.3.3 Randox Laboratories Ltd.
14.3.4 Abbott
14.3.5 Danaher
14.3.6 Biocompare
14.3.7 Vitro Scient
14.3.8 Merck
14.3.9 Biosystems S.A.
